As cited in the business intelligence report titled ‘GLOBAL Medical Aesthetics Market 2019-2028’, available with Market Study Report, global medical aesthetics market is anticipated to exhibit a compound annual growth rate of 5.53% over the forecast period of 2019-2028.
 

According to credible research analysts, rising adoption of home-use aesthetic products coupled with growing popularity of the treatment are spurring global medical aesthetics market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552858/
 

Innovative product launches, rising disposable incomes in developed as well as emerging countries, and strategic collaborations among market players are further propelling industry expansion.
 

Furthermore, high inclination among patients towards using non-invasive surgical procedures along with ongoing technological advancements in the business space are stimulating global medical aesthetics market outlook.
 

On the contrary, high costs of implantable medical devices, concerns over the risks as well as side-effects associated with medical aesthetic procedures, and growing occurrence of malpractices such as sale of counterfeit products are likely to obstruct business development in the forthcoming years.
 

Elaborating on regional outlook, the market spans across Asia-Pacific, Latin America, Europe, North America, and Middle East & Africa.
 

Among these, Asia-Pacific medical aesthetics market is predicted to experience considerable expansion through 2028, owing to rising per capita income, growing cognizance regarding personal aesthetics, advent of technological advancements, growing population, and rapid development in medical tourism industry.
 

With regards to competitive landscape, Zimmer Biomet, Ipsen Pharma GmbH, Allergan Inc., Lumenis (U.K.) Ltd., Galderma S.A., Institut Straumann AG, InMode (Formerly Invasix), Cutera Inc., Candela Corporation, Sientra Inc., Merz Pharma GmbH & Co. KGaA, Johnson & Johnson, Bausch Health Companies Inc. (Formerly Valeant Pharmaceuticals), and Cynosure LLC are the leading companies operating in global medical aesthetics market space.